Senior Pharmacovigilance Officer

About us The Cancer Research UK & UCL Cancer Trials Centre (CTC) is a UKCRC registered centre: and is one of the largest cancer trials centres in the UK, with more than 120 members of staff working on about 100 clinical studies.

The CTC designs and conducts high quality clinical trials, from phase I to phase III trials, with a range of different treatments such as chemo therapies, radiotherapy, surgery and the new generation of targeted drugs including advanced cell and gene therapies.

About the role

We are looking for a Senior Pharmacovigilance Officer to work within our Regulatory team. With the support of the Pharmacovigilance Manager, the main purpose of the post is to maintain oversight of safety reporting activities within the CTC, ensuring patient safety and compliance with regulatory requirements are maintained at all times.

The postholder will review SUSAR reports, raising queries with the trial teams and make timely submissions into ICSR Submissions and Eudra Vigilance portals, maintain oversight over SUSAR submissions and review and submit DSURs to the MHRA. A full list of duties and responsibilities can be found in the job description and person specification which can be accessed at the bottom of this page.

This is a full-time, open-ended post, funded for 1 year in the first instance.

Appointments will usually be made at the bottom of the salary scale.

The CTC offers hybrid working with staff being able to work between the office and home. A minimum of 60% FTE office attendance is required for this role.

If you have any queries about the role, please contact ctc.hr.ukUse of AI in applications:
Applications that rely heavily on AI tools are often generic and lack the detail needed to assess relevant skills and experience. We therefore encourage applicants to limit their use of AI and to follow the instructions in the person specification for their application.

About youThe postholder should have significant knowledge of biomedical or life sciences, as well as significant knowledge and experience of pharmacovigilance in an academic sponsor’s setting.

Experience in safety reporting to competent authorities and REC, using ICR Submissions and Eudra Vigilance and preparing DSURs is essential. Knowledge of cancer biology and treatments would be advantageous.

What we offer

As well as the exciting opportunities this role presents, we also offer some great benefits some of which are below:41 Days holiday (27 days annual leave 8 bank holiday and 6 closure days)
Additional 5 days’ annual leave purchase scheme

Defined benefit career average revalued earnings pension scheme (CARE)
Cycle to work scheme and season ticket loan Immigration loan Relocation scheme for certain posts

On-Site nursery

On-site gym Enhanced maternity, paternity and adoption pay Employee assistance programme:

Staff Support Service Discounted medical insurance

Visit to find out more.

Our commitment to Equality, Diversity and Inclusion As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong.

We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce.

These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women.

Our department (UCL Cancer Institute) holds an Athena SWAN Gold award, in recognition of our long-term commitment and 'beacon' status in advancing gender equality.

You can read more about our commitment to Equality, Diversity and Inclusion here :